Xianhao Zhou

Xianhao Zhou

Auto-generated profile, based on publicly available information

Xianhao Zhou

Biomanufacturing Center, Department of Mechanical Engineering, Tsinghua University, Beijing, 100084, PR China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in Bioactive Materials
Verified
Journal Article
Open access
ZZZhenrui Zhang
Zhenrui Zhang
XZXianhao Zhou
Xianhao Zhou
Yongcong FangYongcong Fang
Yongcong Fang
Zhuo XiongZhuo Xiong
Zhuo Xiong
TZTing Zhang
Ting Zhang
In recent decades, 3D bioprinting has garnered significant research attention due to its ability to manipulate biomaterials and cells to create complex structures precisely. However, due to technological and cost constraints, the clinical translation of 3D bioprinted products (BPPs) from bench to bedside has been hindered by challenges in terms of personalization of design and scaling up of production. Recently, the emerging applications of artificial intelligence (AI) technologies have significantly improved the performance of 3D bioprinting. However, the existing literature remains deficient in a methodological exploration of AI technologies' potential to overcome these challenges in advancing 3D bioprinting toward clinical application. This paper aims to present a systematic methodology for AI-driven 3D bioprinting, structured within the theoretical framework of Quality by Design (QbD). This paper commences by introducing the QbD theory into 3D bioprinting, followed by summarizing the technology roadmap of AI integration in 3D bioprinting, including multi-scale and multi-modal sensing, data-driven design, and in-line process control. This paper further describes specific AI applications in 3D bioprinting's key elements, including bioink formulation, model structure, printing process, and function regulation. Finally, the paper discusses current prospects and challenges associated with AI technologies to further advance the clinical translation of 3D bioprinting.

31 December 2023 in Advanced Materials
Verified
Journal Article
Closed access
XMXingwu Mo
Xingwu Mo
YZYanmei Zhang
Yanmei Zhang
ZWZixuan Wang
Zixuan Wang
XZXianhao Zhou
Xianhao Zhou
ZZZhenrui Zhang
Zhenrui Zhang
Zhuo XiongZhuo Xiong
Zhuo Xiong